{"id":76763,"date":"2021-07-31T16:48:53","date_gmt":"2021-07-31T20:48:53","guid":{"rendered":"http:\/\/stateofthenation.co\/?p=76763"},"modified":"2021-07-31T16:50:18","modified_gmt":"2021-07-31T20:50:18","slug":"isnt-this-why-big-pharma-owns-and-operates-the-u-s-congress-and-both-major-parties","status":"publish","type":"post","link":"http:\/\/stateofthenation.co\/?p=76763","title":{"rendered":"Isn&#8217;t this why <i>Big Pharma<\/i> owns and operates the U.S. Congress and both Major Parties?"},"content":{"rendered":"<h1><strong>Drugmakers Funnel Millions To Lawmakers; A Few Dozen Get<br \/>\n$100,000-Plus<\/strong><\/h1>\n<p><!--more-->By Emmarie Huetteman and Sydney Lupkin<br \/>\nKHN<\/p>\n<p>Before the midterm elections heated up, dozens of drugmakers had already poured about $12 million into the war chests of hundreds of members of Congress.<\/p>\n<p>Since the beginning of last year, 34 lawmakers have each received more than $100,000 from pharmaceutical companies. Two of those \u2014 Reps. Greg Walden of Oregon, a key Republican committee chairman, and Kevin McCarthy of California, the House Republican majority leader \u2014 each received more than $200,000, a new Kaiser Health News database shows.<\/p>\n<p>As voters prepare to go to the polls, they can use a new database, <a href=\"https:\/\/khn.org\/campaign\" target=\"_blank\" rel=\"noopener noreferrer\">\u201cPharma Cash to Congress,\u201d<\/a> tracking up to 10 years of pharmaceutical company contributions to any or all members of Congress, illuminating drugmakers\u2019 efforts to influence legislation.<\/p>\n<div class=\"nosyndication\">\n<figure class=\"layout-lg\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-881600\" src=\"https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/1-money-by-cycle4.png\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" srcset=\"https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/1-money-by-cycle4.png 1350w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/1-money-by-cycle4.png?resize=150,144 150w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/1-money-by-cycle4.png?resize=500,481 500w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/1-money-by-cycle4.png?resize=768,740 768w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/1-money-by-cycle4.png?resize=1270,1223 1270w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/1-money-by-cycle4.png?resize=120,116 120w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/1-money-by-cycle4.png?resize=170,164 170w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/1-money-by-cycle4.png?resize=300,289 300w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/1-money-by-cycle4.png?resize=315,303 315w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/1-money-by-cycle4.png?resize=630,607 630w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/1-money-by-cycle4.png?resize=1200,1156 1200w\" alt=\"\" width=\"1024\" height=\"986\" \/><\/figure>\n<\/div>\n<p>The drug industry ranks among lawmakers\u2019 most generous patrons. In the past decade, Congress has received $79 million from 68 pharma political action committees, or PACs, run by employees of companies that make drugs treating everything from cancer to erectile dysfunction.<\/p>\n<p>&nbsp;<\/p>\n<aside class=\"related partner-box \">\n<div class=\"related-content\">This story also ran on <a href=\"https:\/\/www.thedailybeast.com\/reps-greg-walden-and-kevin-mccarthy-get-tons-of-money-from-big-pharma?ref=home\">The Daily Beast<\/a>. <span class=\"republish-story\">This story can be republished for free (<a href=\"https:\/\/khn.org\/news\/drugmakers-funnel-millions-to-lawmakers-a-few-dozen-get-100000-plus\/view\/republish\/\" rel=\"nofollow\">details<\/a>). <\/span><a href=\"http:\/\/www.thedailybeast.com\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter\" src=\"https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2014\/10\/logo-daily-beast-18.png\" alt=\"\" width=\"85\" height=\"18\" \/><\/a><\/div>\n<\/aside>\n<p>Drugmakers\u2019 campaign contributions have reached record-breaking levels in recent years as skyrocketing drug prices have become a hot-button political issue. By June 30, 52 PACs funded by pharmaceutical companies and their trade organizations had given about $12 million to members of Congress for this election cycle. It is unclear whether drugmakers will top their previous 10-year record of $16 million, given during the 2016 election season.<\/p>\n<p>&nbsp;<\/p>\n<p>While PAC contributions to candidates are limited, a larger donation frequently accompanies individual contributions from the company\u2019s executives and other employees. It also sends a clear message to the recipient, campaign finance experts say, one they may remember when lobbyists come calling: There\u2019s more where that came from.<\/p>\n<p>The KHN analysis shows that pharmaceutical companies tend to play the field, giving to a wide swath of lawmakers on both sides of the aisle.<\/p>\n<div class=\"nosyndication\">\n<figure class=\"layout-lg\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-882483\" src=\"https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/2-money-2018-by-party_corrected.png\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" srcset=\"https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/2-money-2018-by-party_corrected.png 1350w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/2-money-2018-by-party_corrected.png?resize=147,150 147w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/2-money-2018-by-party_corrected.png?resize=491,500 491w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/2-money-2018-by-party_corrected.png?resize=768,782 768w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/2-money-2018-by-party_corrected.png?resize=1247,1270 1247w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/2-money-2018-by-party_corrected.png?resize=120,122 120w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/2-money-2018-by-party_corrected.png?resize=170,173 170w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/2-money-2018-by-party_corrected.png?resize=300,306 300w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/2-money-2018-by-party_corrected.png?resize=500,509 500w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/2-money-2018-by-party_corrected.png?resize=315,321 315w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/2-money-2018-by-party_corrected.png?resize=630,642 630w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/2-money-2018-by-party_corrected.png?resize=1200,1222 1200w\" alt=\"\" width=\"1024\" height=\"1043\" \/><\/figure>\n<\/div>\n<p>The drug industry favors power. Since the beginning of 2017, drugmakers contributed to 217 Republicans and 187 Democrats, giving only slightly more on average to Republicans, who currently control both chambers of Congress. This was also the case for Democrats during the 2010 election cycle, when they controlled Congress.<\/p>\n<div class=\"wp-caption alignright\"><span class=\"embed-youtube\"><iframe loading=\"lazy\" id=\"widget2\" class=\"youtube-player\" src=\"https:\/\/www.youtube.com\/embed\/TnrClFcmp4w?version=3&amp;rel=1&amp;showsearch=0&amp;showinfo=1&amp;iv_load_policy=1&amp;fs=1&amp;hl=en-US&amp;autohide=2&amp;wmode=transparent&amp;enablejsapi=1\" width=\"400\" height=\"225\" sandbox=\"allow-scripts allow-same-origin allow-popups allow-presentation\" allowfullscreen=\"allowfullscreen\" data-mce-fragment=\"1\"><\/iframe><\/span><\/div>\n<p>As with other industries, drugmakers tend to give more to lawmakers in leadership roles. For example, Rep. Paul Ryan, a Wisconsin Republican, became speaker of the House halfway through the 2016 election cycle, prompting drugmakers to pour $75,000 more into his war chest than they had the previous cycle.<\/p>\n<p>Money also tends to flow to congressional committees with jurisdiction over pharmaceutical issues that can affect things like drug pricing and FDA approval. Walden, a nine-term Republican congressman, has watched his coffers swell with help from drugmaker PACs since he became chairman of the powerful House Committee on Energy and Commerce in early 2017.<\/p>\n<div class=\"nosyndication\">\n<figure class=\"layout-lg\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-882484\" src=\"https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/3-money-2018-by-chamber_corrected.png\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" srcset=\"https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/3-money-2018-by-chamber_corrected.png 1350w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/3-money-2018-by-chamber_corrected.png?resize=134,150 134w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/3-money-2018-by-chamber_corrected.png?resize=447,500 447w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/3-money-2018-by-chamber_corrected.png?resize=768,859 768w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/3-money-2018-by-chamber_corrected.png?resize=1135,1270 1135w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/3-money-2018-by-chamber_corrected.png?resize=120,134 120w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/3-money-2018-by-chamber_corrected.png?resize=170,190 170w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/3-money-2018-by-chamber_corrected.png?resize=300,336 300w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/3-money-2018-by-chamber_corrected.png?resize=500,559 500w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/3-money-2018-by-chamber_corrected.png?resize=315,352 315w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/3-money-2018-by-chamber_corrected.png?resize=630,705 630w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/3-money-2018-by-chamber_corrected.png?resize=1200,1342 1200w\" alt=\"\" width=\"1024\" height=\"1145\" \/><\/figure>\n<\/div>\n<p>With six months to go in the 2018 cycle, Walden had already raised an additional $71,000 over the 2016 cycle \u2014 or 11 times more than drugmakers gave him a decade ago.<\/p>\n<p>Asked to comment on the increase in Walden\u2019s contributions from drugmakers, Zach Hunter, his committee spokesman, called attention to Walden\u2019s work to lower prescription drug prices and said \u201cno member of Congress has done more\u201d to end the opioid crisis.<\/p>\n<p>Pharmaceutical company PACs also gave to dozens of other members of committees, such as the Senate Committee on Health, Education, Labor and Pensions. And they appear to target congressional districts that are home to their headquarters and other facilities.<\/p>\n<p>The PAC for Purdue Pharma, the embattled opioid manufacturer, gave to only a handful of members this cycle. However, it focused much of its giving on lawmakers from North Carolina, its headquarters for manufacturing and technical operations.<\/p>\n<figure class=\"layout-lg\"><\/figure>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-large wp-image-76765\" src=\"http:\/\/stateofthenation.co\/wp-content\/uploads\/2021\/07\/4-money-2018-by-company3-473x1024.png\" alt=\"\" width=\"473\" height=\"1024\" srcset=\"http:\/\/stateofthenation.co\/wp-content\/uploads\/2021\/07\/4-money-2018-by-company3-473x1024.png 473w, http:\/\/stateofthenation.co\/wp-content\/uploads\/2021\/07\/4-money-2018-by-company3-138x300.png 138w, http:\/\/stateofthenation.co\/wp-content\/uploads\/2021\/07\/4-money-2018-by-company3-768x1664.png 768w, http:\/\/stateofthenation.co\/wp-content\/uploads\/2021\/07\/4-money-2018-by-company3-709x1536.png 709w, http:\/\/stateofthenation.co\/wp-content\/uploads\/2021\/07\/4-money-2018-by-company3-945x2048.png 945w, http:\/\/stateofthenation.co\/wp-content\/uploads\/2021\/07\/4-money-2018-by-company3.png 1200w\" sizes=\"auto, (max-width: 473px) 100vw, 473px\" \/><\/p>\n<aside class=\"related related-slab pull-right\">\n<div class=\"slab default-slab \">\n<h3><a href=\"https:\/\/www.reddit.com\/r\/iama\">REDDIT AMA <\/a><\/h3>\n<div class=\"slab-container\">\n<div class=\"slab-content\">\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-882102\" src=\"https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/amaproof.jpg\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" srcset=\"https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/amaproof.jpg 640w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/amaproof.jpg?resize=150,113 150w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/amaproof.jpg?resize=500,375 500w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/amaproof.jpg?resize=120,90 120w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/amaproof.jpg?resize=170,128 170w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/amaproof.jpg?resize=300,225 300w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/amaproof.jpg?resize=315,236 315w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/amaproof.jpg?resize=630,473 630w\" alt=\"\" width=\"640\" height=\"480\" \/><\/p>\n<p>We are Jay Hancock and Emmarie Huetteman and we\u2019re talking about Kaiser Health News\u2019 new database and ongoing reporting showing how pharma industry tries to influence Congress with millions in political donations. Ask Us Anything!<\/p>\n<\/div>\n<div class=\"link-button\"><a class=\"btn btn-default btn-block\" href=\"https:\/\/www.reddit.com\/r\/iama\">WE&#8217;LL BE LIVE ON 10\/18 AT 12 P.M. ET <\/a><\/div>\n<\/div>\n<\/div>\n<\/aside>\n<p>This election cycle, 28 percent of lawmakers did not receive any contributions from pharmaceutical PACs.<\/p>\n<p>Under federal law, corporations cannot donate directly to political candidates. Exploiting a common loophole, they instead set up PACs, funded by money collected from employees. Those PACs then donate to campaigns, which are free to spend that money as they wish on necessities like advertising or campaign events.<\/p>\n<p>Campaign contributions tell only part of the story. Drugmakers also spend millions of dollars lobbying members of Congress directly and give to patient advocacy groups, which provide patients to testify on Capitol Hill and organize social media campaigns on drugmakers\u2019 behalf.<\/p>\n<p><a href=\"https:\/\/khn.org\/news\/patient-advocacy-groups-take-in-millions-from-drugmakers-is-there-a-payback\/\" target=\"_blank\" rel=\"noopener noreferrer\">A previous investigation by Kaiser Health News<\/a>, <a href=\"https:\/\/khn.org\/patient-advocacy\/\" target=\"_blank\" rel=\"noopener noreferrer\">\u201cPre$cription for Power,\u201d<\/a>examined charitable giving by top drugmakers and found that 14 of them donated a combined $116 million to patient advocacy groups in 2015 alone.<\/p>\n<div class=\"nosyndication\">\n<div id=\"attachment_827994\" class=\"wp-caption aligncenter\">\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-881566\" src=\"https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2018\/10\/5-patient-advocacy-and-lobbying3.png\" alt=\"\" width=\"1024\" height=\"1305\" aria-describedby=\"caption-attachment-827994\" \/><\/p>\n<p id=\"caption-attachment-827994\" class=\"wp-caption-text\">To learn more about how Kaiser Health News built the Pre$cription for Power database, read our <a href=\"https:\/\/khn.org\/patient-advocacy\/#methodology\" target=\"_blank\" rel=\"noopener noreferrer\">methodology<\/a>.<\/p>\n<\/div>\n<\/div>\n<aside class=\"related related-slab pull-right\">\n<div class=\"slab default-slab \">\n<h3>PRE$CRIPTION FOR POWER<\/h3>\n<div class=\"slab-container\">\n<div class=\"slab-content\">\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-853205\" src=\"https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2017\/12\/patient_advocacy_1_570x300.jpg\" sizes=\"auto, (max-width: 570px) 100vw, 570px\" srcset=\"https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2017\/12\/patient_advocacy_1_570x300.jpg 570w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2017\/12\/patient_advocacy_1_570x300.jpg?resize=150,79 150w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2017\/12\/patient_advocacy_1_570x300.jpg?resize=500,263 500w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2017\/12\/patient_advocacy_1_570x300.jpg?resize=120,63 120w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2017\/12\/patient_advocacy_1_570x300.jpg?resize=170,89 170w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2017\/12\/patient_advocacy_1_570x300.jpg?resize=300,158 300w, https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2017\/12\/patient_advocacy_1_570x300.jpg?resize=315,166 315w\" alt=\"\" width=\"570\" height=\"300\" \/><\/p>\n<ul>\n<li>\u2014 <a href=\"https:\/\/khn.org\/news\/patient-advocacy-groups-take-in-millions-from-drugmakers-is-there-a-payback\/\" target=\"_blank\" rel=\"noopener\">Patient Advocacy Groups Take In Millions From Drugmakers. Is There A Payback?<\/a><\/li>\n<li>\u2014 <a href=\"https:\/\/khn.org\/patient-advocacy\/\" target=\"_blank\" rel=\"noopener\">Explore the Database<\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/aside>\n<p>And like other industries, pharmaceutical companies wield their political power in ways veiled from the public, giving to \u201c<a href=\"https:\/\/khn.org\/news\/drug-trade-group-quietly-spends-dark-money-to-sway-policy-and-voters\/\" target=\"_blank\" rel=\"noopener noreferrer\">dark money\u201d groups<\/a> and super PACs \u2014 independent groups barred from directly donating to or coordinating with campaigns \u2014 bent on swaying lawmaking.<\/p>\n<p>Brendan Fischer, who directs federal reform programs at the Campaign Legal Center, cautioned that a campaign contribution from a corporate PAC does not directly translate into a vote in the drugmaker\u2019s favor.<\/p>\n<p>\u201cContributions help keep the door open for company lobbyists,\u201d he said.<\/p>\n<p><em>KHN data editor Elizabeth Lucas contributed to this story.<\/em><\/p>\n<p class=\"credits\"><em>KHN\u2019s coverage of prescription drug development, costs and pricing is supported in part by the <a href=\"http:\/\/www.arnoldfoundation.org\/\">Laura and John Arnold Foundation<\/a>.<\/em><\/p>\n<p>___<br \/>\n<a href=\"https:\/\/khn.org\/news\/drugmakers-funnel-millions-to-lawmakers-a-few-dozen-get-100000-plus\/\">https:\/\/khn.org\/news\/drugmakers-funnel-millions-to-lawmakers-a-few-dozen-get-100000-plus\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Drugmakers Funnel Millions To Lawmakers; A Few Dozen Get $100,000-Plus<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-76763","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts\/76763","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=76763"}],"version-history":[{"count":0,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts\/76763\/revisions"}],"wp:attachment":[{"href":"http:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=76763"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=76763"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=76763"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}